Horizon Therapeutics (HZNP) – Hot Comments
-
Horizon (HZNP) tumbles on potential FTC lawsuit to block Amgen deal; Analysts surprised
-
Wells Fargo Reiterates Equal Weight Rating on Horizon Therapeutics (HZNP) as Potential FTC Lawsuit Increases Risk to Amgen (AMGN) Deal
-
-
-
-
-
-
-
-
-
-
Back to HZNP Stock Lookup